Logo image of FTRP.CA

FIELD TRIP HEALTH LTD (FTRP.CA) Stock Fundamental Analysis

Canada - TSX:FTRP - CA31656R1029 - Common Stock

3.74 CAD
+0.25 (+7.16%)
Last: 9/9/2022, 7:00:00 PM
Fundamental Rating

2

FTRP gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 15 industry peers in the Health Care Providers & Services industry. FTRP has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, FTRP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year FTRP has reported negative net income.
In the past 5 years FTRP always reported negative net income.
FTRP had a negative operating cash flow in each of the past 5 years.
FTRP.CA Yearly Net Income VS EBIT VS OCF VS FCFFTRP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -10M -20M -30M -40M -50M

1.2 Ratios

Industry RankSector Rank
ROA -53.55%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FTRP.CA Yearly ROA, ROE, ROICFTRP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -20 -40 -60 -80 -100

1.3 Margins

Industry RankSector Rank
OM -1091.39%
PM (TTM) -1125.3%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FTRP.CA Yearly Profit, Operating, Gross MarginsFTRP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 -500 -1K -1.5K -2K

More info and screens

3

2. Health

2.1 Basic Checks

FTRP does not have a ROIC to compare to the WACC, probably because it is not profitable.
FTRP has more shares outstanding than it did 1 year ago.
FTRP has a worse debt/assets ratio than last year.
FTRP.CA Yearly Shares OutstandingFTRP.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M
FTRP.CA Yearly Total Debt VS Total AssetsFTRP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 1.86 indicates that FTRP is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.40 indicates that FTRP is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 1.86
ROIC/WACCN/A
WACC8.28%
FTRP.CA Yearly LT Debt VS Equity VS FCFFTRP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M 100M

2.3 Liquidity

FTRP has a Current Ratio of 8.20. This indicates that FTRP is financially healthy and has no problem in meeting its short term obligations.
FTRP has a Quick Ratio of 8.20. This indicates that FTRP is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 8.2
Quick Ratio 8.2
FTRP.CA Yearly Current Assets VS Current LiabilitesFTRP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for FTRP have decreased strongly by -15.25% in the last year.
FTRP shows a strong growth in Revenue. In the last year, the Revenue has grown by 471.78%.
EPS 1Y (TTM)-15.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.89%
Revenue 1Y (TTM)471.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%225.3%

3.2 Future

FTRP is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.94% yearly.
Based on estimates for the next years, FTRP will show a very strong growth in Revenue. The Revenue will grow by 99.77% on average per year.
EPS Next Y-20.59%
EPS Next 2Y-10.54%
EPS Next 3Y-2.39%
EPS Next 5Y0.94%
Revenue Next Year267.08%
Revenue Next 2Y77.85%
Revenue Next 3Y91.55%
Revenue Next 5Y99.77%

3.3 Evolution

FTRP.CA Yearly Revenue VS EstimatesFTRP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 20M 40M 60M
FTRP.CA Yearly EPS VS EstimatesFTRP.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FTRP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FTRP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FTRP.CA Price Earnings VS Forward Price EarningsFTRP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -3.7
FTRP.CA Per share dataFTRP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

FTRP's earnings are expected to decrease with -2.39% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.54%
EPS Next 3Y-2.39%

More info and screens

0

5. Dividend

5.1 Amount

FTRP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FIELD TRIP HEALTH LTD

TSX:FTRP (9/9/2022, 7:00:00 PM)

3.74

+0.25 (+7.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)02-15 2022-02-15
Inst Owners2.11%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap217.49M
Revenue(TTM)4.86M
Net Income(TTM)-54691140
Analysts82.22
Price Target62.48 (1570.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 44.75
P/FCF N/A
P/OCF N/A
P/B 3.25
P/tB N/A
EV/EBITDA -3.7
EPS(TTM)-0.96
EYN/A
EPS(NY)-1.16
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.08
BVpS1.15
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -53.55%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -1091.39%
PM (TTM) -1125.3%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.2
Quick Ratio 8.2
Altman-Z 1.86
F-Score2
WACC8.28%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.89%
EPS Next Y-20.59%
EPS Next 2Y-10.54%
EPS Next 3Y-2.39%
EPS Next 5Y0.94%
Revenue 1Y (TTM)471.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%225.3%
Revenue Next Year267.08%
Revenue Next 2Y77.85%
Revenue Next 3Y91.55%
Revenue Next 5Y99.77%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

FIELD TRIP HEALTH LTD / FTRP.CA FAQ

Can you provide the ChartMill fundamental rating for FIELD TRIP HEALTH LTD?

ChartMill assigns a fundamental rating of 3 / 10 to FTRP.CA.


What is the valuation status of FIELD TRIP HEALTH LTD (FTRP.CA) stock?

ChartMill assigns a valuation rating of 1 / 10 to FIELD TRIP HEALTH LTD (FTRP.CA). This can be considered as Overvalued.


What is the profitability of FTRP stock?

FIELD TRIP HEALTH LTD (FTRP.CA) has a profitability rating of 0 / 10.


How financially healthy is FIELD TRIP HEALTH LTD?

The financial health rating of FIELD TRIP HEALTH LTD (FTRP.CA) is 6 / 10.